Market Cap 33.51B
Revenue (ttm) 4.03B
Net Income (ttm) 576.20M
EPS (ttm) N/A
PE Ratio 51.44
Forward PE 41.81
Profit Margin 14.29%
Debt to Equity Ratio 0.55
Volume 2,328,300
Avg Vol 3,699,740
Day's Range N/A - N/A
Shares Out 392.11M
Stochastic %K 17%
Beta 1.44
Analysts Strong Sell
Price Target $99.68

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized thir...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
smartkarma
smartkarma Jul. 12 at 5:01 AM
$DXCM | DexCom Eyes Explosive Growth with Game-Changing Type 2 Strategy—Is This Its Biggest Pivot Yet? "DexCom’s latest earnings and strategy pivot have reignited investor attention as the company recalibrates its focus on the vast, underpenetrated..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/dexcom-eyes-explosive-growth-with-game-changing-type-2-strategy-is-this-its-biggest-pivot-yet
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 5:42 PM
$DXCM this will crash I am telling you
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 5:36 PM
$DXCM Monday is put day as well
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 4:20 PM
$DXCM fixing mistake about the law suits
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 3:45 PM
$DXCM some bad news coming
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 3:01 PM
$DXCM Dxcm don’t got no margin hope this fall another 3-4%
2 · Reply
ckjamesst
ckjamesst Jul. 11 at 2:52 PM
$DXCM hope it touches that base fib
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 12:51 AM
$DXCM market is uncertain take us to mid 70s
1 · Reply
ckjamesst
ckjamesst Jul. 10 at 2:47 AM
$DXCM 5% move either side tomorrow
1 · Reply
ckjamesst
ckjamesst Jul. 9 at 8:39 PM
$DXCM love how they manipulate the more they do it the more money in my bank
2 · Reply
Latest News on DXCM
The Best Growth Stocks to Buy

Jul 8, 2025, 8:12 AM EDT - 4 days ago

The Best Growth Stocks to Buy

ALGM AMZN AVGO BURL CTRE DAR GE


DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

May 9, 2025, 11:00 AM EDT - 2 months ago

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure


DexCom: Growth Is Reaccelerating But Don't Ignore The Risks

May 5, 2025, 4:34 AM EDT - 2 months ago

DexCom: Growth Is Reaccelerating But Don't Ignore The Risks


DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:04 PM EDT - 2 months ago

DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript


DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Apr 10, 2025, 11:34 AM EDT - 3 months ago

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance


Dexcom Appoints Jon Coleman as Chief Commercial Officer

Mar 25, 2025, 4:05 PM EDT - 3 months ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer


Dexcom Appoints Renée Galá to Board of Directors

Mar 10, 2025, 8:30 AM EDT - 4 months ago

Dexcom Appoints Renée Galá to Board of Directors


DexCom Gets FDA Warning Letter After Inspections of Facilities

Mar 7, 2025, 5:33 PM EST - 4 months ago

DexCom Gets FDA Warning Letter After Inspections of Facilities


Dexcom Announces Upcoming Conference Presentation

Feb 27, 2025, 8:30 AM EST - 4 months ago

Dexcom Announces Upcoming Conference Presentation


Quality Key in Volatile Market, NFLX & DXCM Value Plays

Feb 21, 2025, 3:48 PM EST - 5 months ago

Quality Key in Volatile Market, NFLX & DXCM Value Plays

NFLX


DexCom Analysts Increase Their Forecasts After Q4 Earnings

Feb 14, 2025, 9:22 AM EST - 5 months ago

DexCom Analysts Increase Their Forecasts After Q4 Earnings


DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 9:33 PM EST - 5 months ago

DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript


Dexcom forecasts 2025 revenue mostly in-line with expectations

Jan 13, 2025, 7:43 AM EST - 6 months ago

Dexcom forecasts 2025 revenue mostly in-line with expectations


DexCom, Abbott Agree to Settlement in Patent Litigation

Dec 23, 2024, 4:56 PM EST - 7 months ago

DexCom, Abbott Agree to Settlement in Patent Litigation

ABT


Abbott and DexCom settle glucose monitor patent disputes

Dec 23, 2024, 4:17 PM EST - 7 months ago

Abbott and DexCom settle glucose monitor patent disputes

ABT


smartkarma
smartkarma Jul. 12 at 5:01 AM
$DXCM | DexCom Eyes Explosive Growth with Game-Changing Type 2 Strategy—Is This Its Biggest Pivot Yet? "DexCom’s latest earnings and strategy pivot have reignited investor attention as the company recalibrates its focus on the vast, underpenetrated..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/dexcom-eyes-explosive-growth-with-game-changing-type-2-strategy-is-this-its-biggest-pivot-yet
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 5:42 PM
$DXCM this will crash I am telling you
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 5:36 PM
$DXCM Monday is put day as well
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 4:20 PM
$DXCM fixing mistake about the law suits
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 3:45 PM
$DXCM some bad news coming
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 3:01 PM
$DXCM Dxcm don’t got no margin hope this fall another 3-4%
2 · Reply
ckjamesst
ckjamesst Jul. 11 at 2:52 PM
$DXCM hope it touches that base fib
0 · Reply
ckjamesst
ckjamesst Jul. 11 at 12:51 AM
$DXCM market is uncertain take us to mid 70s
1 · Reply
ckjamesst
ckjamesst Jul. 10 at 2:47 AM
$DXCM 5% move either side tomorrow
1 · Reply
ckjamesst
ckjamesst Jul. 9 at 8:39 PM
$DXCM love how they manipulate the more they do it the more money in my bank
2 · Reply
ckjamesst
ckjamesst Jul. 9 at 5:07 PM
$DXCM so much manipulation
1 · Reply
iSilenT
iSilenT Jul. 9 at 4:56 PM
$SENS Honestly $TNDM should buyout $SENS . This would open up the CGM market for them, then they can eventually phase out support for $DXCM . That would be the best strategy, very cut throat, dog eat dog strategy, but they would instantly dominate the CGM market by offering a complete CGM solution. However, Abbott $ABT would not allow this to happen of course. I wonder who is going to make the first move soon 🤔. $TNDM is slowly losing competitiveness due to their reliance on third party use of their pump system. They need to improve their core competency and offer the FULL CGM solution.
1 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jul. 9 at 3:18 PM
$DXCM Barrons. Accurate.
2 · Reply
ckjamesst
ckjamesst Jul. 9 at 3:09 PM
$DXCM bearish engulfed
1 · Reply
ckjamesst
ckjamesst Jul. 9 at 1:03 PM
$DXCM Dxcm Will double down as per analyst but when ?
0 · Reply
Stock_Guy_69
Stock_Guy_69 Jul. 9 at 10:41 AM
$DXCM Idiot bear posts a bunch about his feelings… If you listen to some prick here about his feelings, you deserve what’s coming for you…
2 · Reply
ckjamesst
ckjamesst Jul. 9 at 10:39 AM
$DXCM feels like huge drop is coming…
0 · Reply
ckjamesst
ckjamesst Jul. 9 at 10:36 AM
$DXCM but let see
0 · Reply
ckjamesst
ckjamesst Jul. 9 at 10:35 AM
$DXCM Tariff will affect market because deal is not done. Tariff is too high, inflation, no cut on interest, hit credit hard is just I feel like it will go back to 65 at some point
0 · Reply
ckjamesst
ckjamesst Jul. 9 at 10:02 AM
$DXCM I don’t know it will have retest some levels I feel like before shooting up. Daily we have morning star
0 · Reply
JInvestTrade
JInvestTrade Jul. 8 at 9:02 PM
$SENS this was posted on LinkedIn recently. Bringing awareness to $SENS eversense 365 CGM. $DXCM, $ABOTT, $TNDM, $PODD https://www.linkedin.com/posts/arizona-adces_azadces-diabetescare-eversense365-activity-7348431742283730948--dRO?utm_source=share&utm_medium=member_ios&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 2:21 PM
Biosensors market projected to hit $54B by 2030 with 9.5% CAGR. $DXCM called out as key player in wearable tech driving growth. But with Medicare reimbursement headwinds and 63x P/E, investors must decide if the CGM leader can outpace sector risks. https://www.prnewswire.com/news-releases/biosensors-market-worth-54-37-billion-by-2030---exclusive-report-by-marketsandmarkets-302499808.html
0 · Reply